Advertisement

Abdominal Imaging

, Volume 33, Issue 5, pp 501–511 | Cite as

Hepatocellular cancer response to radiofrequency tumor ablation: contrast-enhanced ultrasound

  • Tommaso Vincenzo BartolottaEmail author
  • Adele Taibbi
  • Massimo Midiri
  • Marcello De Maria
Article

Abstract

Radiofrequency ablation (RFA) is increasingly being used as percutaneous treatment of choice for patients with early stage hepatocellular carcinoma (HCC). An accurate assessment of the RFA therapeutic response is of crucial importance, considering that a complete tumor ablation significantly increases patient survival, whereas residual unablated tumor calls for additional treatment. Imaging modalities play a pivotal role in accomplishing this task, but ultrasound (US) is not considered a reliable modality for the evaluation of the real extent of necrosis, even when color/power Doppler techniques are used. Recently, newer microbubble-based US contrast agents used in combination with grey-scale US techniques, which are very sensitive to non-linear behavior of microbubbles, have been introduced. These features have opened new prospects in liver ultrasound and may have a great impact on daily practice, including cost-effective assessment of therapeutic response of percutaneous ablative therapies. Technical evolution of CEUS focusing on findings after RFA are illustrated. These latter are detailed, cross-referenced with the literature and discussed on the basis of our personal experience. Timing of CEUS posttreatment assessment among with advantages and limitations of CEUS are also described with a perspective on further technologic refinement.

Key words

Radiofrequency ablation Contrast-enhanced ultrasound Hepatocellular carcinoma Liver, percutaneous ablation therapy Liver, sonography 

References

  1. 1.
    Lencioni R, Dalla Pina C, Bartolozzi C (2005) Percutaneous image-guided radiofrequency ablation in the therapeutic management of hepatocellular carcinoma. Abdom Imaging 30:401–408PubMedCrossRefGoogle Scholar
  2. 2.
    Choi D, Lim HK, Rhim H, et al. (2007) Percutaneous radiofrequency ablation for early-stage hepatocellular carcinoma as a first-line treatment: long-term results and prognostic factors in a large single-institution series. Eur Radiol 17:684–692PubMedCrossRefGoogle Scholar
  3. 3.
    Lin SM, Lin CJ, Lin CC, Hsu CW, Chen YC (2005) Randomised controlled trial comparing percutaneous radiofrequency thermal ablation, percutaneous ethanol injection, and percutaneous acetic acid injection to treat hepatocellular carcinoma of 3 cm or less. Gut 54:1151–1156PubMedCrossRefGoogle Scholar
  4. 4.
    Livraghi T, Goldberg SN, Lazzaroni S, et al. (2001) Hepatocellular carcinoma: radio-frequency ablation of medium and large lesions. Radiology 218:918–929Google Scholar
  5. 5.
    Lencioni R, Cioni D, Crocetti L, et al. (2005) Early stage hepatocellular carcinoma in patients with cirrhosis: long-term results of percutaneous image-guided radiofrequency ablation. Radiology 234:961–967PubMedCrossRefGoogle Scholar
  6. 6.
    Ni Y, Mulier S, Miao Y, Michel L, Marchal G (2005) A review of the general aspects of radiofrequency ablation. Abdom Imaging 30:381–400PubMedCrossRefGoogle Scholar
  7. 7.
    Laeseke PF, Frey TM, Brace CL, et al. (2007) Multiple-electrode radiofrequency ablation of hepatic malignancies: initial clinical experience. AJR 188:1485–1494PubMedCrossRefGoogle Scholar
  8. 8.
    Dodd GD 3rd, Soulen MC, Kane RA, et al. (2000) Minimally invasive treatment of malignant hepatic tumors: at the threshold of a major breakthrough. Radiographics 20:9–27PubMedGoogle Scholar
  9. 9.
    Nakazawa T, Kokubu S, Shibuya A, et al. (2007) Radiofrequency ablation of hepatocellular carcinoma: correlation between local tumor progression after ablation and ablative margin. AJR 188:480–488PubMedCrossRefGoogle Scholar
  10. 10.
    Goldberg SN, Charboneau JW, Dodd GD, et al. (2003) Image-guided tumor ablation: proposal for standardization of terms and reporting criteria. Radiology 228:335–345PubMedCrossRefGoogle Scholar
  11. 11.
    Dodd GD, Frank MS, Aribandi M, Chopra S, Chintapalli KN (2001) Radiofrequency thermal ablation: computer analysis of the size of the thermal injury created by overlapping ablations. AJR 177:777–782PubMedGoogle Scholar
  12. 12.
    Mulier S, Ni Y, Frich L, et al. (2007) Experimental and clinical radiofrequency ablation: proposal for standardized description of coagulation size and geometry. Ann Surg Oncol 14:1381–1396PubMedCrossRefGoogle Scholar
  13. 13.
    Rhim H (2005) Complications of radiofrequency ablation in hepatocellular carcinoma. Abdom Imaging 30:409–418PubMedCrossRefGoogle Scholar
  14. 14.
    Mulier S, Ni Y, Miao Y, et al. (2003) Size and geometry of hepatic radiofrequency lesions. Eur J Surg Oncol 29:867–878PubMedCrossRefGoogle Scholar
  15. 15.
    Stippel DL, Brochhagen HG, Arenja M, et al. (2004) Variability of size and shape of necrosis induced by radiofrequency ablation in human livers: a volumetric evaluation. Ann Surg Oncol 11:420–425PubMedCrossRefGoogle Scholar
  16. 16.
    Montgomery RS, Rahal A, Dodd GD 3rd, et al. (2004) Radiofrequency ablation of hepatic tumors: variability of lesion size using a single ablation device. AJR Am J Roentgenol 182:657–661PubMedGoogle Scholar
  17. 17.
    Kim SK, Rhim H, Kim YS, et al. (2005) Radiofrequency thermal ablation of hepatic tumors: pitfalls and challenges. Abdom Imaging 30:727–733PubMedCrossRefGoogle Scholar
  18. 18.
    Sala M, Llovet JM, Vilana R, et al. (2004) Initial response to percutaneous ablation predicts survival in patients with hepatocellular carcinoma. Hepatology 40:1352–1360PubMedCrossRefGoogle Scholar
  19. 19.
    Cammà C, Di Marco V, Orlando A, et al. (2005) Treatment of hepatocellular carcinoma in compensated cirrhosis with radio-frequency thermal ablation (RFTA): a prospective study. J Hepatol 42:535–540PubMedCrossRefGoogle Scholar
  20. 20.
    Goldberg SN, Gazelle GS, Mueller PR (2000) Thermal ablation therapy for focal malignancy: a unified approach to underlying principles, techniques, and diagnostic imaging guidance. AJR Am J Roentgenol 174:323–331PubMedGoogle Scholar
  21. 21.
    Goldberg SN, Grassi CJ, Cardella JF, et al. (2005) Image-guided tumor ablation: standardization of terminology and reporting criteria. Radiology 235:728–339PubMedCrossRefGoogle Scholar
  22. 22.
    Lencioni R, Cioni D, Bartolozzi C (2001) Percutaneous radiofrequency thermal ablation of liver malignancies: techniques, indications, imaging findings, and clinical results. Abdom Imaging 26:345–360PubMedCrossRefGoogle Scholar
  23. 23.
    Dromain C, de Baere T, Elias D, et al. (2002) Hepatic tumors treated with percutaneous radio-frequency ablation: CT and MR imaging follow-up. Radiology 223:255–262PubMedCrossRefGoogle Scholar
  24. 24.
    Lu DS, Yu NC, Raman SS, et al. (2005) Radiofrequency ablation of hepatocellular carcinoma: treatment success as defined by histologic examination of the explanted liver. Radiology 234:954–960PubMedCrossRefGoogle Scholar
  25. 25.
    Morimoto M, Sugimori K, Shirato K (2002) Treatment of hepatocellular carcinoma with radiofrequency ablation: radiologic-histologic correlation during follow-up periods. Hepatology 35:1467–1475PubMedCrossRefGoogle Scholar
  26. 26.
    Goldberg SN, Gazelle GS, Compton CC, Mueller PR, Tanabe KK (2000) Treatment of intrahepatic malignancy with radiofrequency ablation: radiologic-pathologic correlation. Cancer 88:2452–2463PubMedCrossRefGoogle Scholar
  27. 27.
    Catalano O, Lobianco R, Esposito M, Siani A (2001) Hepatocellular carcinoma recurrence after percutaneous ablation therapy: helical CT patterns. Abdom Imaging 26:375–83PubMedCrossRefGoogle Scholar
  28. 28.
    Limanond P, Zimmerman P, Raman SS, Kadell BM, Lu DS (2003) Interpretation of CT and MRI after radiofrequency ablation of hepatic malignancies. AJR 181:1635–1640PubMedGoogle Scholar
  29. 29.
    Kim SK, Lim HK, Kim YH, et al. (2003) Hepatocellular carcinoma treated with radio-frequency ablation: spectrum of imaging findings. Radiographics 23:107–121PubMedCrossRefGoogle Scholar
  30. 30.
    Lim HK, Choi D, Lee WJ, et al. (2001) Hepatocellular carcinoma treated with percutaneous radio-frequency ablation: evaluation with follow-up multiphase helical CT. Radiology 221:447–454PubMedCrossRefGoogle Scholar
  31. 31.
    Nour SG, Lewin JS (2005) Radiofrequency thermal ablation: the role of MR imaging in guiding and monitoring tumor therapy. Magn Reson Imaging Clin N Am 13:561–81PubMedCrossRefGoogle Scholar
  32. 32.
    Clasen S, Boss A, Schmidt D, et al. (2006) Magnetic resonance imaging for hepatic radiofrequency ablation. Eur J Radiol 59:140–148PubMedCrossRefGoogle Scholar
  33. 33.
    Lencioni R, Caramella D, Bartolozzi C (1995) Hepatocellular carcinoma: use of color Doppler US to evaluate response to treatment with percutaneous ethanol injection. Radiology. 194:113–118PubMedGoogle Scholar
  34. 34.
    Koito K, Namieno T, Ichimura T, et al. (2000) Power Doppler sonography: evaluation of hepatocellular carcinoma after treatment with transarterial embolization or percutaneous ethanol injection therapy. AJR 174:337–341PubMedGoogle Scholar
  35. 35.
    Solbiati L, Goldberg SN, Ierace T, et al. (1997) Hepatic metastases: percutaneous radio-frequency ablation with cooled-tip electrodes. Radiology 205:367–373PubMedGoogle Scholar
  36. 36.
    Lencioni R, Goletti O, Armillotta N, et al. (1998) Radio-frequency thermal ablation of liver metastases with a cooled-tip electrode needle: results of a pilot clinical trial. Eur Radiol. 8:1205–1211PubMedCrossRefGoogle Scholar
  37. 37.
    Solbiati L, Ierace T, Goldberg SN, et al. (1997) Percutaneous US-guided radio-frequency tissue ablation of liver metastases: treatment and follow-up in 16 patients. Radiology 202:195–20PubMedGoogle Scholar
  38. 38.
    Choi D, Lim HK, Kim SH, et al. (2000) Hepatocellular carcinoma treated with percutaneous radio-frequency ablation: usefulness of power Doppler US with a microbubble contrast agent in evaluating therapeutic response-preliminary results. Radiology 217:558–563PubMedGoogle Scholar
  39. 39.
    Leyendecker JR, Dodd GD 3rd, Halff GA, et al. (2002) Sonographically observed echogenic response during intraoperative radiofrequency ablation of cirrhotic livers: pathologic correlation. AJR 178:1147–1151PubMedGoogle Scholar
  40. 40.
    Raman SS, Lu DS, Vodopich DJ, et al. (2000) Creation of radiofrequency lesions in a porcine model: correlation with sonography, CT, and histopathology. AJR Am J Roentgenol 175:1253–1258PubMedGoogle Scholar
  41. 41.
    Goldberg SN, Gazelle GS, Solbiati L, et al. (1998) Ablation of liver tumors using percutaneous RF therapy. AJR 170:1023–1028PubMedGoogle Scholar
  42. 42.
    Catalano O, Lobianco R, Cusati B, Siani A (2004) Hepatocellular carcinoma: spectrum of contrast-enhanced gray-scale harmonic sonography findings. Abdom Imaging 29:341–347PubMedGoogle Scholar
  43. 43.
    Bartolotta TV, Midiri M, Galia M, et al. (2007) Characterization of benign hepatic tumors arising in fatty liver with SonoVue and pulse inversion US. Abdom Imaging 32:84–91PubMedCrossRefGoogle Scholar
  44. 44.
    Bartolotta TV, Midiri M, Quaia E, et al. (2005) Benign focal liver lesions: spectrum of findings on SonoVue-enhanced pulse-inversion ultrasonography. Eur Radiol 15:1643–1649PubMedCrossRefGoogle Scholar
  45. 45.
    Quaia E, Calliada F, Bertolotto M, et al. (2004) Characterization of focal liver lesions with contrast-specific US modes and a sulfur hexafluoride-filled microbubble contrast agent: diagnostic performance and confidence. Radiology 2004 232:420–430Google Scholar
  46. 46.
    Burns PN, Wilson SR (2007) Focal liver masses: enhancement patterns on contrast-enhanced images—concordance of US scans with CT scans and MR images. Radiology 242:162–174PubMedCrossRefGoogle Scholar
  47. 47.
    Wilson SR, Burns PN (2006) An algorithm for the diagnosis of focal liver masses using microbubble contrast-enhanced pulse-inversion sonography. AJR 186:1401–1412PubMedCrossRefGoogle Scholar
  48. 48.
    Bartolotta TV, Taibbi A, Galia M, et al. (2007) Characterization of hypoechoic focal hepatic lesions in patients with fatty liver: diagnostic performance and confidence of contrast-enhanced ultrasound. Eur Radiol 17:650–661PubMedCrossRefGoogle Scholar
  49. 49.
    Bartolozzi C, Lencioni R, Ricci P, et al. (1998) Hepatocellular carcinoma treatment with percutaneous ethanol injection: evaluation with contrast-enhanced color Doppler US. Radiology 209:387–393PubMedGoogle Scholar
  50. 50.
    Solbiati L, Goldberg SN, Ierace T, et al. (1999) Radio-frequency tissue ablation of hepatic metastases: postprocedural assessment with a US microbubble contrast agent-early experience. Radiology 211:643–649PubMedGoogle Scholar
  51. 51.
    Choi D, Lim HK, Kim SH, et al. (2000) Hepatocellular carcinoma treated with percutaneous radio-frequency ablation: usefulness of power Doppler US with a microbubble contrast agent in evaluating therapeutic response-preliminary results. Radiology 217:558–563PubMedGoogle Scholar
  52. 52.
    Burns PN, Wilson SR, Simpson DH (2000) Pulse inversion imaging of liver blood flow: improved method for characterizing focal masses with microbubble contrast. Invest Radiol 35: 58–71PubMedCrossRefGoogle Scholar
  53. 53.
    Burns PN, Hope Simpson D, Averkiou M (2000) Nonlinear imaging. Ultrasound Med Biol 6:19–22CrossRefGoogle Scholar
  54. 54.
    Wilson SR, Burns PN, Muradali D, et al. (2000) Harmonic hepatic US with microbubble contrast agent: initial experience showing improved characterization of hemangioma, hepatocellular carcinoma, and metastasis. Radiology 215:153–161PubMedGoogle Scholar
  55. 55.
    Dill-Macky MJ, Burns PN, Khalili K, Wilson SR (2002) Focal hepatic masses: enhancement patterns with SH U 508 A and Pulse-Inversion US. Radiology 22:95–102Google Scholar
  56. 56.
    Isozaki T, Numata K, Kiba T, et al. (2003) Differential diagnosis of hepatic tumors by using contrast enhancement patterns at US. Radiology 229:798–805PubMedCrossRefGoogle Scholar
  57. 57.
    Bartolotta TV, Midiri M, Scialpi M, et al. (2004) Focal nodular hyperplasia in normal and fatty liver: a qualitative and quantitative evaluation with contrast-enhanced ultrasound. Eur Radiol 14:583–591PubMedCrossRefGoogle Scholar
  58. 58.
    Quaia E, Bartolotta TV, Midiri M, et al. (2006) Analysis of different contrast enhancement patterns after microbubble-based contrast agent injection in liver hemangiomas with atypical appearance on baseline scan. Abdom Imaging 31:59–64PubMedCrossRefGoogle Scholar
  59. 59.
    Bartolotta TV, Midiri M, Galia M, et al. (2003) Atypical liver hemangiomas: contrast enhancement patterns with SH U 508A and pulse-inversion US. Radiol Med 106:320–328Google Scholar
  60. 60.
    Albrecht T, Blomley MJ, Burns PN, et al. (2003) Improved detection of hepatic metastases with pulse-inversion US during the liver-specific phase of SHU 508A: multicenter study. Radiology 227:361–370PubMedCrossRefGoogle Scholar
  61. 61.
    Morimoto M, Nozawa A, Numata K, et al. (2005) Evaluation using contrast-enhanced harmonic gray scale sonography after radio frequency ablation of small hepatocellular carcinoma: sonographic-histopathologic correlation. J Ultrasound Med 24:273–283PubMedGoogle Scholar
  62. 62.
    Choi D, Lim HK, Lee WJ, et al. (2003) Early assessment of the therapeutic response to radio frequency ablation for hepatocellular carcinoma: utility of gray scale harmonic ultrasonography with a microbubble contrast agent. J Ultrasound Med. 22:1163–1172PubMedGoogle Scholar
  63. 63.
    Ding H, Kudo M, Onda H, et al. (2001) Evaluation of posttreatment response of hepatocellular carcinoma with contrast-enhanced coded phase-inversion harmonic US: comparison with dynamic CT. Radiology 221:721–730PubMedCrossRefGoogle Scholar
  64. 64.
    Kim CK, Choi D, Lim HK, et al. (2005) Therapeutic response assessment of percutaneous radiofrequency ablation for hepatocellular carcinoma: utility of contrast-enhanced agent detection imaging. Eur J Radiol 56:66–73PubMedCrossRefGoogle Scholar
  65. 65.
    Wen YL, Kudo M, Zheng RQ, et al. (2003) Radiofrequency ablation of hepatocellular carcinoma: therapeutic response using contrast-enhanced coded phase-inversion harmonic sonography. AJR 181:57–63PubMedGoogle Scholar
  66. 66.
    Cioni D, Lencioni R, Rossi S, et al. (2001) Radiofrequency thermal ablation of hepatocellular carcinoma: using contrast-enhanced harmonic power doppler sonography to assess treatment outcome. AJR 177:783–788PubMedGoogle Scholar
  67. 67.
    Numata K, Isozaki T, Ozawa Y, et al. (2003) Percutaneous ablation therapy guided by contrast-enhanced sonography for patients with hepatocellular carcinoma. AJR Am J Roentgenol 180:143–149PubMedGoogle Scholar
  68. 68.
    Minami Y, Kudo M, Chung H, et al. (2007) Contrast harmonic sonography-guided radiofrequency ablation therapy versus B-mode sonography in hepatocellular carcinoma: prospective randomized controlled trial. AJR 188:489–494PubMedCrossRefGoogle Scholar
  69. 69.
    Minami Y, Kudo M, Kawasaki T, Chung H, Ogawa C, Shiozaki H (2004) Treatment of hepatocellular carcinoma with percutaneous radiofrequency ablation: usefulness of contrast harmonic sonography for lesions poorly defined with B-mode sonography. AJR 183:153–156PubMedGoogle Scholar
  70. 70.
    Correas JM, Bridal L, Lesavre A, et al. (2001) Ultrasound contrast agent: properties, principles of action, tolerance, and artifacts Eur Radiol 11:1316–1328PubMedCrossRefGoogle Scholar
  71. 71.
    Choi H, Loyer EM, DuBrow RA, et al. (2001) Radio-frequency ablation of liver tumors: assessment of therapeutic response and complications. Radiographics 21:S41–54PubMedGoogle Scholar
  72. 72.
    Lim HS, Jeong YY, Kang HK, Kim JK, Park JG (2006) Imaging features of hepatocellular carcinoma after transcatheter arterial chemoembolization and radiofrequency ablation. AJR 187:W341–349PubMedCrossRefGoogle Scholar
  73. 73.
    Ding H, Kudo M, Onda H, Suetomi Y, Minami Y, Maekawa K (2001) Hepatocellular carcinoma: depiction of tumor parenchymal flow with intermittent harmonic power Doppler US during the early arterial phase in dual-display mode. Radiology 220:349–356PubMedGoogle Scholar
  74. 74.
    Meloni MF, Goldberg SN, Livraghi T, et al. (2001) Hepatocellular carcinoma treated with radiofrequency ablation: comparison of pulse inversion contrast-enhanced harmonic sonography, contrast-enhanced power Doppler sonography, and helical CT. AJR Am J Roentgenol 177:375-80PubMedGoogle Scholar
  75. 75.
    Wang JH, Lu SN, Tung HD, et al. (2006) Flash-echo contrast sonography in the evaluation of response of small hepatocellular carcinoma to percutaneous ablation. J Clin Ultrasound 34:161–168PubMedCrossRefGoogle Scholar
  76. 76.
    Nicolau C, Vilana R, Catala V, et al. (2006) Importance of evaluating all vascular phases on contrast-enhanced sonography in the differentiation of benign from malignant focal liver lesions. AJR 186:158–167PubMedCrossRefGoogle Scholar
  77. 77.
    Nicolau C, Brù C (2004) Focal liver lesions: evaluation with contrast-enhanced ultrasonography. Abdom Imaging 29:348–359PubMedCrossRefGoogle Scholar
  78. 78.
    Catala V, Nicolau C, Vilana R, et al. (2007) Characterization of focal liver lesions: comparative study of contrast-enhanced ultrasound versus spiral computed tomography. Eur Radiol 17:1066-1073PubMedCrossRefGoogle Scholar
  79. 79.
    Brannigan M, Burns PN, Wilson SR (2004) Blood flow patterns in focal liver lesions at microbubble-enhanced US. Radiographics. 24:921–935PubMedCrossRefGoogle Scholar
  80. 80.
    Bartolotta TV, Midiri M, Quaia E, et al. (2005) Liver haemangiomas undetermined at grey-scale ultrasound: contrast-enhancement patterns with SonoVue and pulse-inversion US. Eur Radiol 15:685–693PubMedCrossRefGoogle Scholar
  81. 81.
    Quaia E (2007) Contrast-specific ultrasound techniques. Radiol Med 112:473–490CrossRefGoogle Scholar
  82. 82.
    Lencioni R (2006) European Federation of Societies for Ultrasound in Medicine and Biology (EFSUMB) Impact of European Federation of Societies for Ultrasound in Medicine and Biology (EFSUMB) guidelines on the use of contrast agents in liver ultrasound. Eur Radiol Jul 16:1610–1613Google Scholar
  83. 83.
    Solbiati L, Ierace T, Tonolini M, Cova L (2004) Guidance and monitoring of radiofrequency liver tumor ablation with contrast-enhanced ultrasound. Eur J Radiol 51:S19–S23PubMedCrossRefGoogle Scholar
  84. 84.
    Dill-Macky MJ, Asch M, Burns P, Wilson S (2006) Radiofrequency ablation of hepatocellular carcinoma: predicting success using contrast-enhanced sonography. AJR Am J Roentgenol 186:S287–S295PubMedCrossRefGoogle Scholar
  85. 85.
    Vilana R, Bianchi L, Varela M, et al. (2006) Is microbubble-enhanced ultrasonography sufficient for assessment of response to percutaneous treatment in patients with early hepatocellular carcinoma? Eur Radiol 16:2454–2462PubMedCrossRefGoogle Scholar
  86. 86.
    Meloni MF, Livraghi T, Filice C, Lazzaroni S, Calliada F, Perretti L (2006) Radiofrequency ablation of liver tumors: the role of microbubble ultrasound contrast agents. Ultrasound Q 22:41–47PubMedGoogle Scholar
  87. 87.
    Kono Y, Lucidarme O, Choi SH, et al. (2007) Contrast-enhanced ultrasound as a predictor of treatment efficacy within 2 weeks after transarterial chemoembolization of hepatocellular carcinoma. J Vasc Interv Radiol 18:57–65PubMedCrossRefGoogle Scholar
  88. 88.
    Solbiati L, Tonolini M, Cova L (2004) Monitoring RF ablation. Eur Radiol 14(Suppl 8):P34–42PubMedGoogle Scholar
  89. 89.
    Limanond P, Zimmerman P, Raman SS, Kadell BM, Lu DS (2003) Interpretation of CT and MRI after radiofrequency ablation of hepatic malignancies. AJR 181:1635–1640PubMedGoogle Scholar
  90. 90.
    Sironi S, Livraghi T, Meloni F, et al. (1999) Small hepatocellular carcinoma treated with percutaneous RF ablation: MR imaging follow-up. AJR 173:1225–1229PubMedGoogle Scholar
  91. 91.
    Bolondi L, Gaiani S, Celli N, et al. (2005) Characterization of small nodules in cirrhosis by assessment of vascularity: the problem of hypovascular hepatocellular carcinoma. Hepatology 42:27–34PubMedCrossRefGoogle Scholar
  92. 92.
    Nicolau C, Català V, Vilana R, et al. (2004) Evaluation of hepatocellular carcinoma using SonoVue, a second generation ultrasound contrast agent: correlation with cellular differentiation. Eur Radiol 14:1092–1099PubMedCrossRefGoogle Scholar
  93. 93.
    Goldberg SN, Walovitch RC, Straub JA, Shore MT, Gazelle GS (1999) Radio-frequency-induced coagulation necrosis in rabbits: immediate detection at US with a synthetic microsphere contrast agent. Radiology 213:438–444PubMedGoogle Scholar
  94. 94.
    Imai Y, Okamoto N, Tateiwa N, et al. (2006) Assessment of treatment efficacy in radiofrequency ablation for hepatocellular carcinoma: comparison between multiplanar reconstruction by multi-detector row CT and contrast-enhanced ultrasonography by Truagent detection mode. Hepatol Res 35:69–75PubMedCrossRefGoogle Scholar
  95. 95.
    Pompili M, Riccardi L, Covino M, et al. (2005) Contrast-enhanced gray-scale harmonic ultrasound in the efficacy assessment of ablation treatments for hepatocellular carcinoma. Liver Int 25:954–961PubMedCrossRefGoogle Scholar
  96. 96.
    Bruix J, Sherman M, Llovet JM, et al. (2001) Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol 35:421–430PubMedCrossRefGoogle Scholar
  97. 97.
    Buscarini E, Savoia A, Brambilla G, et al. (2005) Radiofrequency thermal ablation of liver tumors. Eur Radiol 15:884–894PubMedCrossRefGoogle Scholar
  98. 98.
    Bartolotta TV, Midiri M, Galia M, Runza G, Bellia M, Lagalla R (2005) Usefulness of sonovue-enhanced pulse-inversion ultrasonography to assess hepatocellular carcinoma response after percutaneous radiofrequency thermal ablation therapy [Abstract]. In: RSNA Assembly and annual meeting program, p 73Google Scholar
  99. 99.
    Colagrande S, La Villa G, Bartolucci M, et al. (2003) Spiral computed tomography versus ultrasound in the follow-up of cirrhotic patients previously treated for hepatocellular carcinoma: a prospective study. J Hepatol 39:93–98PubMedCrossRefGoogle Scholar
  100. 100.
    Nicolau C, Vilana R, Bru C (2004) The use of contrast-enhanced ultrasound in the management of the cirrhotic patient and for detection of HCC. Eur Radiol 14(Suppl 8):P63–71PubMedGoogle Scholar
  101. 101.
    Albrecht H, Stroszczynski C, Felix R, Hünerbein M (2006) Real time 3D (4D) ultrasound-guided percutaneous biopsy of solid tumors. Ultraschall Med 27:324–328PubMedCrossRefGoogle Scholar
  102. 102.
    Varghese T, Techavipoo U, Liu W, et al. (2003) Elastographic measurement of the area and volume of thermal lesions resulting from radiofrequency ablation: pathologic correlation. AJR 181:701–707PubMedGoogle Scholar
  103. 103.
    Hotta N, Maeno T, Ayada M, et al. (2006) Four-dimensional ultrasonography for therapeutic radiofrequency ablation for hepatocellular carcinoma. Hepatogastroenterology 53:521–525PubMedGoogle Scholar
  104. 104.
    Krix M, Plathow C, Essig M, et al. (2005) Monitoring of liver metastases after stereotactic radiotherapy using low-MI contrast-enhanced ultrasound–initial results. Eur Radiol 15:677–684PubMedCrossRefGoogle Scholar
  105. 105.
    Kisaka Y, Hirooka M, Kumagi T, et al. (2006) Usefulness of contrast-enhanced ultrasonography with abdominal virtual ultrasonography in assessing therapeutic response in hepatocellular carcinoma treated with radiofrequency ablation. Liver Int 26:1241–1247PubMedCrossRefGoogle Scholar
  106. 106.
    Hirooka M, Iuchi H, Kumagi T, et al. (2006) Virtual sonographic radiofrequency ablation of hepatocellular carcinoma visualized on CT but not on conventional sonography. AJR 186:S255–260PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2007

Authors and Affiliations

  • Tommaso Vincenzo Bartolotta
    • 1
    Email author
  • Adele Taibbi
    • 1
  • Massimo Midiri
    • 1
  • Marcello De Maria
    • 1
  1. 1.Department of RadiologyUniversity of PalermoPalermoItaly

Personalised recommendations